INVENTRONICS LTD (IVX.CA) Fundamental Analysis & Valuation

TSX-V:IVX • CA4612082095

Current stock price

0.66 CAD
0 (0%)
Last:

This IVX.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. IVX.CA Profitability Analysis

1.1 Basic Checks

  • IVX had positive earnings in the past year.
  • In the past year IVX had a positive cash flow from operations.
  • IVX had positive earnings in 4 of the past 5 years.
  • In the past 5 years IVX always reported a positive cash flow from operatings.
IVX.CA Yearly Net Income VS EBIT VS OCF VS FCFIVX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1M 2M 3M

1.2 Ratios

  • With an excellent Return On Assets value of 4.96%, IVX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • IVX has a better Return On Equity (10.93%) than 100.00% of its industry peers.
  • The Return On Invested Capital of IVX (7.68%) is better than 100.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for IVX is below the industry average of 7.68%.
  • The 3 year average ROIC (5.64%) for IVX is below the current ROIC(7.68%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.96%
ROE 10.93%
ROIC 7.68%
ROA(3y)3.31%
ROA(5y)16.16%
ROE(3y)7.1%
ROE(5y)35.26%
ROIC(3y)5.64%
ROIC(5y)17.23%
IVX.CA Yearly ROA, ROE, ROICIVX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

1.3 Margins

  • IVX has a better Profit Margin (3.42%) than 100.00% of its industry peers.
  • IVX's Profit Margin has declined in the last couple of years.
  • The Operating Margin of IVX (6.44%) is better than 100.00% of its industry peers.
  • In the last couple of years the Operating Margin of IVX has declined.
  • IVX's Gross Margin of 17.86% is in line compared to the rest of the industry. IVX outperforms 50.00% of its industry peers.
  • In the last couple of years the Gross Margin of IVX has remained more or less at the same level.
Industry RankSector Rank
OM 6.44%
PM (TTM) 3.42%
GM 17.86%
OM growth 3Y-32.94%
OM growth 5Y-3.28%
PM growth 3Y-38.49%
PM growth 5Y-22.37%
GM growth 3Y-14.84%
GM growth 5Y-1.22%
IVX.CA Yearly Profit, Operating, Gross MarginsIVX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. IVX.CA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IVX is destroying value.
  • IVX has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for IVX has been increased compared to 5 years ago.
  • The debt/assets ratio for IVX has been reduced compared to a year ago.
IVX.CA Yearly Shares OutstandingIVX.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M
IVX.CA Yearly Total Debt VS Total AssetsIVX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M

2.2 Solvency

  • An Altman-Z score of 2.96 indicates that IVX is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.96, IVX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • IVX has a debt to FCF ratio of 4.75. This is a neutral value as IVX would need 4.75 years to pay back of all of its debts.
  • IVX has a better Debt to FCF ratio (4.75) than 100.00% of its industry peers.
  • A Debt/Equity ratio of 0.79 indicates that IVX is somewhat dependend on debt financing.
  • IVX has a Debt to Equity ratio (0.79) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF 4.75
Altman-Z 2.96
ROIC/WACC0.87
WACC8.81%
IVX.CA Yearly LT Debt VS Equity VS FCFIVX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M 2M 2.5M

2.3 Liquidity

  • A Current Ratio of 3.26 indicates that IVX has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 3.26, IVX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • IVX has a Quick Ratio of 2.12. This indicates that IVX is financially healthy and has no problem in meeting its short term obligations.
  • IVX has a better Quick ratio (2.12) than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.26
Quick Ratio 2.12
IVX.CA Yearly Current Assets VS Current LiabilitesIVX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. IVX.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 555.91% over the past year.
  • The earnings per share for IVX have been decreasing by -17.91% on average. This is quite bad
  • The Revenue has grown by 30.72% in the past year. This is a very strong growth!
  • The Revenue has been growing slightly by 7.90% on average over the past years.
EPS 1Y (TTM)555.91%
EPS 3Y-48.92%
EPS 5Y-17.91%
EPS Q2Q%37.63%
Revenue 1Y (TTM)30.72%
Revenue growth 3Y-16.66%
Revenue growth 5Y7.9%
Sales Q2Q%16.87%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IVX.CA Yearly Revenue VS EstimatesIVX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M

More info and screens

Find the best growth stocksShow best growing peers

5

4. IVX.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 11.00 indicates a reasonable valuation of IVX.
  • IVX's Price/Earnings ratio is rather cheap when compared to the industry. IVX is cheaper than 100.00% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.18, IVX is valued rather cheaply.
Industry RankSector Rank
PE 11
Fwd PE N/A
IVX.CA Price Earnings VS Forward Price EarningsIVX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • 100.00% of the companies in the same industry are more expensive than IVX, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, IVX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.78
EV/EBITDA 6.29
IVX.CA Per share dataIVX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

  • The decent profitability rating of IVX may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. IVX.CA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 23.33%, IVX is a good candidate for dividend investing.
  • The stock price of IVX dropped by -25.00% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • IVX's Dividend Yield is rather good when compared to the industry average which is at 11.67. IVX pays more dividend than 100.00% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, IVX pays a better dividend.
Industry RankSector Rank
Dividend Yield 23.33%

5.2 History

  • IVX has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
IVX.CA Yearly Dividends per shareIVX.CA Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 0 0 0 0 0

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
IVX.CA Yearly Income VS Free CF VS DividendIVX.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500K 1M 1.5M 2M

More info and screens

Find the best dividend stocksShow peers with best dividend

IVX.CA Fundamentals: All Metrics, Ratios and Statistics

INVENTRONICS LTD

TSX-V:IVX (4/13/2026, 7:00:00 PM)

0.66

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners8.93%
Ins Owner ChangeN/A
Market Cap3.21M
Revenue(TTM)8.25M
Net Income(TTM)282.00K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 23.33%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 11
Fwd PE N/A
P/S 0.39
P/FCF 6.78
P/OCF 5.75
P/B 1.25
P/tB 1.25
EV/EBITDA 6.29
EPS(TTM)0.06
EY9.09%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.1
FCFY14.75%
OCF(TTM)0.11
OCFY17.39%
SpS1.69
BVpS0.53
TBVpS0.53
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.85
Profitability
Industry RankSector Rank
ROA 4.96%
ROE 10.93%
ROCE 10.81%
ROIC 7.68%
ROICexc 9.62%
ROICexgc 9.62%
OM 6.44%
PM (TTM) 3.42%
GM 17.86%
FCFM 5.75%
ROA(3y)3.31%
ROA(5y)16.16%
ROE(3y)7.1%
ROE(5y)35.26%
ROIC(3y)5.64%
ROIC(5y)17.23%
ROICexc(3y)6.92%
ROICexc(5y)19%
ROICexgc(3y)6.92%
ROICexgc(5y)19%
ROCE(3y)7.94%
ROCE(5y)24.26%
ROICexgc growth 3Y-41.46%
ROICexgc growth 5Y0.56%
ROICexc growth 3Y-41.46%
ROICexc growth 5Y0.56%
OM growth 3Y-32.94%
OM growth 5Y-3.28%
PM growth 3Y-38.49%
PM growth 5Y-22.37%
GM growth 3Y-14.84%
GM growth 5Y-1.22%
F-Score8
Asset Turnover1.45
Health
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF 4.75
Debt/EBITDA 2.88
Cap/Depr 47.22%
Cap/Sales 1.03%
Interest Coverage 3.96
Cash Conversion 78.62%
Profit Quality 168.09%
Current Ratio 3.26
Quick Ratio 2.12
Altman-Z 2.96
F-Score8
WACC8.81%
ROIC/WACC0.87
Cap/Depr(3y)215.79%
Cap/Depr(5y)196.54%
Cap/Sales(3y)4.97%
Cap/Sales(5y)3.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)555.91%
EPS 3Y-48.92%
EPS 5Y-17.91%
EPS Q2Q%37.63%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)30.72%
Revenue growth 3Y-16.66%
Revenue growth 5Y7.9%
Sales Q2Q%16.87%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1106.82%
EBIT growth 3Y-44.11%
EBIT growth 5Y4.36%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-33.33%
FCF growth 3Y-37.78%
FCF growth 5Y9.87%
OCF growth 1Y-39.5%
OCF growth 3Y-37.55%
OCF growth 5Y-0.14%

INVENTRONICS LTD / IVX.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of INVENTRONICS LTD (IVX.CA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to IVX.CA.


What is the valuation status for IVX stock?

ChartMill assigns a valuation rating of 5 / 10 to INVENTRONICS LTD (IVX.CA). This can be considered as Fairly Valued.


Can you provide the profitability details for INVENTRONICS LTD?

INVENTRONICS LTD (IVX.CA) has a profitability rating of 7 / 10.


Is the dividend of INVENTRONICS LTD sustainable?

The dividend rating of INVENTRONICS LTD (IVX.CA) is 5 / 10 and the dividend payout ratio is 0%.